As of August 28, 2026, Ultragenyx Pharmaceutical Inc. (RARE) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Ultragenyx Pharmaceutical Inc. has a market capitalization of $2.36B, 98.59M shares outstanding, 297 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise
model 15%
• Under 12 months cash (12mo)
Market Data
Market Cap$2.36B
Shares Outstanding98.59M
Float94.50M
Cash$693.03M
DebtN/A
Short InterestN/A
Institutional Holdings
QoQ: ↑ 12.5% shares (2026Q1 vs prior)
297 institutional holders · 113.36M shares
#1
VANGUARD CAPITAL MANAGEMENT LLC
8.38M shares
#2
BlackRock, Inc.
7.30M shares
#3
VANGUARD PORTFOLIO MANAGEMENT LLC
5.39M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest14.96M
Days to Cover8.3
% of Float15.8%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2014-12-31
4
INSIDER TRANSACTION
2026-04-02
4
INSIDER TRANSACTION
2026-03-10
4
INSIDER TRANSACTION
2026-03-03
4
INSIDER TRANSACTION
2026-03-03
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual RARE Dilution Snapshot
Ultragenyx Pharmaceutical Inc. (RARE) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for RARE: 4 on 2026-04-02; 4 on 2026-03-10; 4 on 2026-03-03.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track RARE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RARE — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for RARE
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.